Efficacy and safety of dabrafenib plus trametinib in adults with differentiated thyroid cancer: a randomised, double-blind, placebo-controlled, phase 3 trial

The Lancet Oncology 2026

View at publisher
Authors: Ming Gao, Young Joo Park, Chia-Chi Lin, Monika K Krzyzanowska, Zhiyong Li, Hui-Jen Tsai, Feng Shi, Jianwu Qin, Swee Hsia Choong, Yansong Lin, Yuan Zhang, Jin Hyoung Kang
+5 more Ana O Hoff, Monique Tan, Michael Roughton, Michaela Paul, Lori J. Wirth
DOI: 10.1016/s1470-2045(26)00133-6
Cited by: 1
References: 25

Fields of Study & Subjects

Thyroid Cancer Diagnosis and Treatment Lung Cancer Treatments and Mutations Lung Cancer Research Studies

Publication details

Journal / source
The Lancet Oncology
Publisher
Elsevier BV
Volume
27
Issue
8
Pages
994–1003
Publication date
13 July 2026
Language
EN